A University of Utah Health study examined red‑light photobiomodulation (PBM) as a preventive therapy for repetitive head acceleration events in collegiate football. Twenty‑six Division I athletes were randomized to active or sham transcranial and intranasal PBM over 16 weeks, receiving three weekly sessions. Diffusion MRI showed the sham group developing markers of neuroinflammation, while the active PBM group maintained stable biomarkers, indicating mitigation of impact‑related brain changes. Although limited by sample size, the trial suggests red‑light therapy could protect neural tissue from subclinical damage.

Penn State researchers unveiled ZENN, a zentropy‑embedded neural network that fuses thermodynamic entropy and a data "temperature" parameter to weigh heterogeneous inputs. By separating signal energy from intrinsic noise, ZENN achieves markedly higher prediction fidelity, demonstrated by a 90% accuracy...